RxDoctor Payments Data

Erica Westbrooks, PA

Physician Assistant · Saint Louis, MONPI 1467703975

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $15,814 of the $18,722 with a category attached, or 84.5%. It is spread thinly across 32 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,029, 2.6 times the $2,341 reported in 2021. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,722in general payments, 2019–2025

Across 825 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$2K
  • AbbVie$2K
  • Sanofi$2K
  • Johnson & Johnson$2K
  • Incyte Corporation$1K
  • UCB, Inc.$1K
  • plus $8K from 26 others

What the payments were for

  • Consulting fees$1,0005%
  • Speaking & faculty fees$1,1976%
  • Food & beverage$15,81484%
  • Education$7114%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,722 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$86,155
Medicare patients
364
Services billed
1,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast18$85,616
Dupixent PenDupilumab19$77,425
Clobetasol Propionate161$7,466
Ciclopirox109$4,234
Ketoconazole187$4,017
Metronidazole83$3,999
Doxycycline Hyclate92$2,998
Triamcinolone Acetonide243$2,841
Betamethasone Dipropionate74$2,555
Tretinoin27$1,478
Fluocinonide32$980
Desonide14$755
Minoxidil99$536
Hydrocortisone75$306
ValacyclovirValacyclovir Hcl15$200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$383$85,61618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →